- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2013
- Public Summary Document (PSD) July 2013 PBAC Meeting - PDF
Dabrafenib – July 2013
Dabrafenib, capsules, 50 mg and 75 mg Tafinlar®
Last updated
8 November 2023